July 26, 2020

Moderna announces that the federal biomedical agency BARDA is adding $472 million to its funding, on top of hundreds of millions already committed, one day before its vaccine is scheduled to enter a 30,000-person phase-three trial. The money flows before anyone knows whether the shot works, an arrangement the coverage frames as decisive action rather than a public bet placed on an unproven product.

France24 runs a warm profile calling Fauci “a lifeline for Americans through pandemics and presidencies,” while the BBC publishes a piece debunking what it labels false and misleading vaccine claims circulating online. The two stories run alongside each other, one elevating a single official as trusted authority and the other policing what the public is allowed to doubt about products still in testing.

On Capitol Hill, the Trump administration and Senate Republicans settle on a relief offer to present to Democrats, setting up a standoff over the size and shape of the next aid package as expanded unemployment benefits near their expiration.